HCPLive Network

Evidence for Strong Genetic Selection Against Some Psychiatric Disorders

 
FRIDAY, Jan. 4 (HealthDay News) -- Different evolutionary mechanisms likely support the persistence of various psychiatric disorders, according to a study published in the January issue of JAMA Psychiatry.

Robert A. Power, from King's College London, and colleagues measured the fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse versus their unaffected siblings and the general population in order to assess the level of selection on causal genetic variants. Data were obtained from the Swedish Multi-Generation Register and the Swedish Hospital Discharge Register for 2.3 million individuals in the 1950 to 1970 birth cohort.

The researchers found that affected patients had significantly fewer children (fertility rate range from 0.23 to 0.93), with the exception of women with depression. The reduction in fecundity was greater among men than women. Sisters of patients with schizophrenia and bipolar disorder had significantly increased fecundity, while brothers of patients with schizophrenia and autism showed significantly lower fecundity. Fecundity was significantly increased among all siblings of patients with depression and substance abuse.

Our results suggest that strong selection exists against schizophrenia, autism, and anorexia nervosa and that these variants may be maintained by new mutations or an as-yet unknown mechanism," the authors write. "Vulnerability to depression, and perhaps substance abuse, may be preserved by balancing selection, suggesting the involvement of common genetic variants in ways that depend on other genes and on environment."

One author disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2013 HealthDay. All rights reserved.
 

Further Reading
Researchers assessed the effect of seizure status and severity, medication use, mental health indicators, parental support, and other factors on self-reported quality of life in children with epilepsy.
A group of international researchers led by Luosheng Li, MD, of the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institutet, Karolinska University Hospital in Stockholm, Sweden, recently demonstrated that age-dependent decline in insulin secretion (and thus glucose homeostasis) from the beta cell in experimental mice models is associated with subtle changes in Ca2+ dynamics.
For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the right treatment can make a world of difference in the management of their condition. A recent study looked at how effective inhaled budesonide and systemic methylprednisolone can be for those patients.
More Reading